Marcus A. Ruscetti

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Jason Robert Pitarresi · 4 shared papers, 2024–2026 · strength 0.78
   • Paper Multiplexed cytokine and antigen mRNA administration generates durable anti-tumor immunity against pancreatic cancer. DOI 10.1038/s41467-026-74574-z↗
   • Paper Mitochondrial Ca2+ controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticity. DOI 10.1016/j.celrep.2025.115627↗
   • Paper Pancreatic cancer cachexia is mediated by PTHrP-driven disruption of adipose de novo lipogenesis DOI 10.1101/2025.06.03.657464↗
2. Nikita Bhalerao · 3 shared papers, 2025–2026 · strength 0.61
   • Paper Multiplexed cytokine and antigen mRNA administration generates durable anti-tumor immunity against pancreatic cancer. DOI 10.1038/s41467-026-74574-z↗
   • Paper Mitochondrial Ca2+ controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticity. DOI 10.1016/j.celrep.2025.115627↗
   • Paper Pancreatic cancer cachexia is mediated by PTHrP-driven disruption of adipose de novo lipogenesis DOI 10.1101/2025.06.03.657464↗
3. Jessica Peura · 3 shared papers, 2024–2025 · strength 0.56
   • Paper Mitochondrial Ca2+ controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticity. DOI 10.1016/j.celrep.2025.115627↗
   • Paper Pancreatic cancer cachexia is mediated by PTHrP-driven disruption of adipose de novo lipogenesis DOI 10.1101/2025.06.03.657464↗
   • Paper Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pan… DOI 10.1126/scitranslmed.adj9366↗
4. Loretah Chibaya · 3 shared papers, 2023–2026 · strength 0.52
   • Paper Multiplexed cytokine and antigen mRNA administration generates durable anti-tumor immunity against pancreatic cancer. DOI 10.1038/s41467-026-74574-z↗
   • Paper Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pan… DOI 10.1126/scitranslmed.adj9366↗
   • Paper EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer imm… DOI 10.1038/s43018-023-00553-8↗
5. Chaitanya Naimesh Parikh · 3 shared papers, 2023–2026 · strength 0.52
   • Paper Multiplexed cytokine and antigen mRNA administration generates durable anti-tumor immunity against pancreatic cancer. DOI 10.1038/s41467-026-74574-z↗
   • Paper Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pan… DOI 10.1126/scitranslmed.adj9366↗
   • Paper EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer imm… DOI 10.1038/s43018-023-00553-8↗
6. Brian C Lewis · 1 shared paper, 2026 · strength 0.22
   • Paper Multiplexed cytokine and antigen mRNA administration generates durable anti-tumor immunity against pancreatic cancer. DOI 10.1038/s41467-026-74574-z↗
7. Jillian Weissenrieder · 1 shared paper, 2025 · strength 0.21
   • Paper Mitochondrial Ca2+ controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticity. DOI 10.1016/j.celrep.2025.115627↗
8. James Kevin FOSKETT · 1 shared paper, 2025 · strength 0.21
   • Paper Mitochondrial Ca2+ controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticity. DOI 10.1016/j.celrep.2025.115627↗
9. Ben Z. Stanger · 1 shared paper, 2025 · strength 0.21
   • Paper Mitochondrial Ca2+ controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticity. DOI 10.1016/j.celrep.2025.115627↗
10. Anil K. Rustgi · 1 shared paper, 2025 · strength 0.21
    • Paper Mitochondrial Ca2+ controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticity. DOI 10.1016/j.celrep.2025.115627↗
11. Robert J. Norgard · 1 shared paper, 2025 · strength 0.18
    • Paper Pancreatic cancer cachexia is mediated by PTHrP-driven disruption of adipose de novo lipogenesis DOI 10.1101/2025.06.03.657464↗
12. Michael Anthony Hollingsworth · 1 shared paper, 2025 · strength 0.18
    • Paper Pancreatic cancer cachexia is mediated by PTHrP-driven disruption of adipose de novo lipogenesis DOI 10.1101/2025.06.03.657464↗
13. Paul M. Grandgenett · 1 shared paper, 2025 · strength 0.18
    • Paper Pancreatic cancer cachexia is mediated by PTHrP-driven disruption of adipose de novo lipogenesis DOI 10.1101/2025.06.03.657464↗
14. John P. Morris · 1 shared paper, 2023 · strength 0.14
    • Paper EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer imm… DOI 10.1038/s43018-023-00553-8↗
15. Scott W. Lowe · 1 shared paper, 2023 · strength 0.14
    • Paper EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer imm… DOI 10.1038/s43018-023-00553-8↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.